RESPIRATORY DYSFUNCTION IN CONGESTIVE-HEART-FAILURE - CORRECTION AFTER HEART-TRANSPLANTATION

被引:0
|
作者
NISET, G
NINANE, V
ANTOINE, M
YERNAULT, JC
机构
[1] ERASME UNIV HOSP, DEPT CHEST, ROUTE DE LENNIK 808, B-1070 BRUSSELS, BELGIUM
[2] ERASME UNIV HOSP, CARDIAC REHABIL SERV, B-1070 BRUSSELS, BELGIUM
[3] ERASME UNIV HOSP, DEPT CARDIAC SURG, B-1070 BRUSSELS, BELGIUM
关键词
CHRONIC CONGESTIVE HEART FAILURE; HEART TRANSPLANTATION; LUNG TRANSFER FACTOR; LUNG VOLUMES;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Severe chronic congestive heart failure (CCHF) is known to induce a restrictive ventilatory defect, with a small decrease m lung transfer factor for carbon monoxide (TLCO). The aim of the present work was to assess the reversibility of this dysfunction. We studied a group of 47 patients with CCHF, before and one year after heart transplantation. The measurements included static and dynamic lung volumes, TLCO and cardiac function. On initial evaluation, vital capacity (VC), total lung capacity (TLC) and TLCO were reduced to 76, 79 and 64% of the predicted value (% pred), respectively. Forced expiratory volume in one second (FEV1) was decreased to 69% pred, with a FEV1/VC ratio below 0.70 in 13 out of 47 patients. One year after transplantation, cardiac function had markedly improved, as shown by a normalized left ventricular ejection fraction (from 18% preoperatively to 59% postoperatively), and mean pulmonary wedge pressure (from 26 to 12 mmHg). At this time, VC (94% pred) and TLC (98% pred) were within the normal range, whereas TLCO remained low (67% pred). The FEV1/VC ratio did not change, even in the subgroup with an initial low value. Smoking habits did contribute to the low TLCo and FEV1/VC ratio. In conclusion, respiratory dysfunction induced by CCHF is reversible, with the exception of the reduction in TLCO, which probably reflects permanent changes in the lung vasculature. CCHF does not induce an obstructive ventilatory pattern.
引用
收藏
页码:1197 / 1201
页数:5
相关论文
共 50 条
  • [31] MODE OF DEATH IN PATIENTS WITH CONGESTIVE-HEART-FAILURE - COMPARISON BETWEEN POSSIBLE CANDIDATES FOR HEART-TRANSPLANTATION AND PATIENTS WITH LESS ADVANCED DISEASE
    VANDENBROEK, SAJ
    VANVELDHUISEN, DJ
    DEGRAEFF, PA
    CRIJNS, HJGM
    VANGILST, WH
    HILLEGE, H
    LIE, KI
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1993, 12 (03): : 367 - 371
  • [32] ACE INHIBITORS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE AND RENAL DYSFUNCTION
    HEIDLAND, A
    TESCHNER, M
    GOTZ, R
    [J]. KLINISCHE WOCHENSCHRIFT, 1991, 69 : 65 - 74
  • [33] EFFECTS ON HEART MEMBRANES AFTER TAURINE TREATMENT IN RABBITS WITH CONGESTIVE-HEART-FAILURE
    ELIZAROVA, EP
    ORLOVA, TR
    MEDVEDEVA, NV
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-1 (03): : 308 - 312
  • [34] RISK FOR POSTOPERATIVE CONGESTIVE-HEART-FAILURE
    CHARLSON, ME
    MACKENZIE, CR
    GOLD, JP
    ALES, KL
    TOPKINS, M
    SHIRES, GT
    [J]. SURGERY GYNECOLOGY & OBSTETRICS, 1991, 172 (02): : 95 - 104
  • [35] NITRATE THERAPY FOR CONGESTIVE-HEART-FAILURE
    GUIMARAES, A
    [J]. REVISTA BRASILEIRA DE MEDICINA, 1991, 48 (08) : 528 - &
  • [36] INDORAMIN IN SEVERE CONGESTIVE-HEART-FAILURE
    GRUBE, E
    MANZ, M
    LUDERITZ, B
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 : S117 - S123
  • [37] NEUROHORMONAL MECHANISMS IN CONGESTIVE-HEART-FAILURE
    ALTON, M
    CODY, RJ
    [J]. CURRENT OPINION IN CARDIOLOGY, 1992, 7 (03) : 374 - 380
  • [38] RATIONAL THERAPY OF CONGESTIVE-HEART-FAILURE
    WERNER, MG
    SCHMIEDER, RE
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1993, 82 : 7 - 16
  • [39] ACE INHIBITORS IN CONGESTIVE-HEART-FAILURE
    KANTNER, TR
    [J]. JOURNAL OF FAMILY PRACTICE, 1992, 35 (03): : 305 - 314
  • [40] MANAGEMENT OF REFRACTORY CONGESTIVE-HEART-FAILURE
    CODY, RJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (18): : G141 - G149